Home Healthcare Myasthenia Gravis Disease Market
myasthenia gravis disease market

Myasthenia Gravis Disease Market By Disease Type (Imaging (X-ray, Computed Tomography, Magnetic Resonance Imaging), Blood Tests, Electrodiagnostic, and Edrophonium Test), By Treatment (Medication, Surgery, HSCT), By End-User (Hospitals, Clinics, Academic Research Institutes) By Region, Segments & Forecast, 2018 -2026

  • Published Date: Nov 2018
  • Pages: 114
  • Format: PDF
  • Report ID: PM1546
  • Base Year: 2017
  • Historical Data: 2015-2016

 Table of Contents

  1. Overview and Scope
    1. Research goal & scope
    2. Research assumptions
    3. Research Methodology
      1. Primary data sources
      2. Secondary data sources
    4. Key take-away
    5. Stakeholders
  2. Executive Summary
    1. Market Definition
    2. Market Segmentation
  3. Myasthenia Gravis Disease Market Insights
    1. Myasthenia Gravis Disease Therapies – Industry snapshot
    2. Myasthenia Gravis Disease Therapies - Ecosystem analysis
    3. Myasthenia Gravis Disease Market Dynamics
      1. Myasthenia Gravis Disease Therapies – Market Forces
        1. Myasthenia Gravis Disease Market Driver Analysis
        2. Myasthenia Gravis Disease Market Restraint/Challenges analysis
        3. Myasthenia Gravis Disease Market Opportunity Analysis
    4. Industry analysis - Porter's five force
      1. Bargaining power of supplier
      2. Bargaining power of buyer
      3. Threat of substitute
      4. Threat of new entrant
      5. Degree of competition
    5. Myasthenia Gravis Disease Market PEST Analysis
    6. Myasthenia Gravis Disease Market Value Chain Analysis
    7. Myasthenia Gravis Disease Therapies Industry Trends
    8. Competitive Ranking Analysis, 2017
  4. Myasthenia Gravis Disease Market Size and Forecast, 2017-2026 by Diagnosis
    1. Key Findings
    2. Imaging
      1. X-ray
      2. Computed Tomography (CT)
      3. Magnetic Resonance Imaging (MRI)
      4. Others
    3. Blood Tests
    4. Electrodiagnostic
    5. Edrophonium Test
  5. Myasthenia Gravis Disease Market Size and Forecast, 2017-2026 by Treatment
    1. Key Findings
    2. Medication
    3. Surgery
    4. HSCT
  6. Myasthenia Gravis Disease Market Size and Forecast, 2017-2026 by End User
    1. Key Findings
    2. Hospitals
    3. Clinics
    4. Academic Research Institutes
  7. Myasthenia Gravis Disease Market Size and Forecast, 2017-2026 by Region
    1. Key Findings
    2. North America
      1. U.S.
      2. Canada
    3. Europe
      1. Germany
      2. UK
      3. France
    4. Asia-Pacific
      1. China
      2. India
      3. Japan
    5. Latin America
      1. Brazil
      2. Mexico
    6. Middle East & Africa
  8. Company Profiles
    1. Alexion Pharmaceutical Inc.
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    2. Avadel Pharmaceuticals Plc
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    3. CSL Behring
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    4. Grifols S.A.
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    5. Baxter International Inc.
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    6. Shire Plc
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    7. Novartis AG
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    8. Hoffmann-La Roche AG
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    9. Takeda Pharmaceutical Company Limited
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    10. Valeant Pharmaceuticals International Inc.
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
Polaris Market Research
Myasthenia Gravis Disease Market Size - Industry Report, 2018-2026